How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception: Study on 600 patients on biologic therapy

BACKGROUND: The outbreak of coronavirus disease-2019 (COVID-19) is a public health crisis of global proportion. In psoriatic patients treated with biologic agents, evidence is not yet available on susceptibility to infection with the novel SARS-CoV-2 coronavirus, and data about the perception of COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardini, N., Skroza, N., Spagnoli, A., Marchesiello, A., Balduzzi, V., Tolino, E., Mambrin, A., Michelini, S., Maddalena, P., Volpe, S., Proietti, I., Vestri, A., Potenza, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015377/
https://www.ncbi.nlm.nih.gov/pubmed/34118738
http://dx.doi.org/10.1016/j.jiph.2021.03.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015377/
https://www.ncbi.nlm.nih.gov/pubmed/34118738
http://dx.doi.org/10.1016/j.jiph.2021.03.010

Ejemplares similares